ClinicalTrials.gov
ClinicalTrials.gov Menu

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00418743
Recruitment Status : Unknown
Verified March 2010 by Groupe Francais De Pneumo-Cancerologie.
Recruitment status was:  Recruiting
First Posted : January 5, 2007
Last Update Posted : March 9, 2010
Sponsor:
Collaborators:
Baxter Healthcare Corporation
Amgen
Information provided by:
Groupe Francais De Pneumo-Cancerologie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : May 2010